5-DIAZOURACIL (NSC-23519): A PHASE I STUDY.
D000963:Antimetabolites; D009369:Neoplasms / Q000628:therapy*; D011743:Pyrimidines; D014116:Toxicology; D014498:Uracil / Q000031:analogs & derivatives
D000963:Antimetabolites; D011743:Pyrimidines; C004758:5-diazouracil; D014498:Uracil
ANTIMETABOLITES; NEOPLASM THERAPY; PYRIMIDINES; TOXICOLOGIC REPORT